Impact of Postoperative Complications on Oncologic Outcomes After Rectal Cancer Surgery: An Analysis of the US Rectal Cancer Consortium.
Adriana C Gamboa, Rachel M Lee, Michael K Turgeon...
https://pubmed.ncbi.nlm.nih.gov/32968958/Actively Recruiting
Led by Osijek University Hospital · Updated on 2026-02-20
68
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are investigating how neoadjuvant therapy affects patients with colorectal cancer, focusing on changes in blood vessel function, tissue density, and fibrosis, and how these relate to complications around the time of surgery. The study compares patients who received neoadjuvant therapy with those who had surgery as their first treatment, aiming to understand differences in biomarkers, demographics, and clinical outcomes. This observational study will monitor patients until hospital discharge and track complications for one month after surgery. The study involves two groups 34 patients treated with neoadjuvant therapy and 34 patients who undergo surgery initially without prior therapy. During surgery, a small sample of skin and subcutaneous tissue will be collected for detailed analysis of microvascular density and tissue fibrosis. Blood samples will also be taken before surgery, 16 hours after surgery, and before hospital discharge to assess various laboratory parameters and biomarkers related to inflammation and vascular function. Participants will be followed from surgery through their hospital stay, with ongoing monitoring of postoperative complications via medical records for one month after discharge. The main outcomes measured include microvascular density and skin fibrosis from tissue samples, alongside secondary laboratory markers such as von Willebrand factor, intraoperative hemodynamics, blood transfusions, and inflammation markers. This comprehensive follow-up aims to link tissue changes with clinical complications and recovery.
CONDITIONS
Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer
J
Josipa Glavas Tahtler, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Osijek University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo colorectal cancer surgery during which skin and subcutaneous tissue samples are taken for histopathological analysis. Blood samples are also collected before surgery for laboratory analyses.
1 visit (in-person)
Duration - From surgery until hospital discharge, approximately several days
Participants have blood samples taken 16 hours after surgery and before hospital discharge to monitor laboratory parameters and assess post-operative recovery.
2 visits (in-person)
Duration - 1 month
Participants are followed for one month after discharge through medical history review in the Hospital Information System to track any post-discharge complications.
No in-person visits; data collected through medical records
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Adriana C Gamboa, Rachel M Lee, Michael K Turgeon...
https://pubmed.ncbi.nlm.nih.gov/32968958/Fitalew Tadele Admasu, Tadesse Asmamaw Dejenie, Gashaw Walle Ayehu...
https://pubmed.ncbi.nlm.nih.gov/37205202/David N Hanna, Alexander T Hawkins
https://pubmed.ncbi.nlm.nih.gov/34537139/Sherif Elawa, Ingemar Fredriksson, Ingrid Steinvall...
https://pubmed.ncbi.nlm.nih.gov/38460441/Suee Lee, Seok Jae Huh, Sung Yong Oh...
https://pubmed.ncbi.nlm.nih.gov/28599468/Chien-Chih Chen, Mei-Ling Wu, Kuo-Cheng Huang...
https://pubmed.ncbi.nlm.nih.gov/32387305/Hafeez Afolabi, Salzihan Md Salleh, Zaidi Zakaria...
https://pubmed.ncbi.nlm.nih.gov/36141305/Osijek University Hospital
Lead Sponsor